Dietary Supplements Market Outlook:
Dietary Supplements Market size was valued at USD 160.2 billion in 2025 and is expected to reach USD 362.21 billion by 2035, expanding at around 8.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of dietary supplements is evaluated at USD 172.46 billion.
A growing aging population and rising consumer health consciousness have propelled the global market's recent notable expansion. According to World Health Organization; the percentage of people over 60 in the world will almost treble from 12% to 22% between 2015 and 2050.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of dietary supplements is evaluated at USD 172.46 billion.
The global dietary supplements market size exceeded USD 160.2 billion in 2025 and is set to expand at a CAGR of more than 8.5%, surpassing USD 362.21 billion revenue by 2035.
North America dietary supplements market will hold more than 35% share by 2035, driven by the high prevalence of chronic and non-chronic ailments, along with growing consumer awareness about dietary supplements.
Key players in the market include Pfizer Inc, Bayer AG, Glanbia PLC, Abbott, Archer Daniels Midland Company, Herbalife International of America, Inc., GlaxoSmithKline plc, Himalaya Global Holdings Ltd., Amway Corporation.
